UBS Group’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-170,000
Closed -$3.53M 10684
2026
Q1
$3.53M Buy
+170,000
New +$4.02M ﹤0.01% 4430
2025
Q4
Sell
-126,000
Closed -$7.15M 10795
2025
Q3
$7.15M Sell
126,000
-62,800
-33% -$3.22M ﹤0.01% 3659
2025
Q2
$9.41M Sell
188,800
-66,600
-26% -$3.01M ﹤0.01% 3143
2025
Q1
$7.55M Buy
+255,400
New +$9.49M ﹤0.01% 3354

Other funds holding HIMS

UBS Group's HIMS Position: Q2 2026 in Review

UBS Group reduced its Hims & Hers Health (HIMS) stake by 36% in Q2 2026, selling an estimated $40M and leaving 2,660,810 shares worth $92.3M. The position accounts for 0.01% of the portfolio, ranked #1182.

UBS Group first reported a position in HIMS in Q2 2020 and has held it in 23 quarters since. The position peaked at $162M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • UBS Group held 2,660,810 shares of Hims & Hers Health worth $92.3M as of Q2 2026.
  • UBS Group sold 1,490,828 Hims & Hers Health shares in Q2 2026, an estimated $40M.
  • Hims & Hers Health made up 0.01% of UBS Group's portfolio in Q2 2026, its #1182 holding.
  • UBS Group first reported a position in Hims & Hers Health in Q2 2020 and has held it in 23 quarters since.
  • UBS Group's Hims & Hers Health position peaked at $162M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.